Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 Fluorescence Imaging of Nerves during Surgery 2019
2019 Panitumumab-IRDye800CW for Fluorescence-Guided Surgical Resection of Colorectal Cancer 2019
2019 Proceedings: Pathways for successful translation of new imaging agents and modalities—phase III studies 2019
2019 Genetic strategy to decrease complement activation with adenoviral therapies 2019
2019 Adjuvant anti-angiogenic therapy enhances chemotherapeutic uptake in a murine model of head and neck cancer * 2019
2019 Surgical margins in oral cavity squamous cell carcinoma: Current practices and future directions 2019
2018 Determination of tumor margins with surgical specimen mapping using near-infrared fluorescence 2018
2018 Evaluation of optical imaging agents in a fluorescence-guided surgical model of head and neck cancer 2018
2018 Evaluation of fluorescence-guided surgery agents in a murine model of soft tissue fibrosarcoma 2018
2018 Recommendations for reporting on emerging optical imaging agents to promote clinical approval 2018
2018 Safety of panitumumab-IRDye800CW and cetuximab-IRDye800CW for fluorescence-guided surgical navigation in head and neck cancers. 2018
2017 Characterizing the detection threshold for optical imaging in surgical oncology 2017
2017 Fluorescence Imaging for Cancer Screening and Surveillance 2017
2017 T 1-Enhanced MRI-visible nanoclusters for imaging-guided drug delivery 2017
2017 Sensitivity and specificity of cetuximab-IRDye800CW to identify regional metastatic disease in head and neck cancer 2017
2017 Effects of an Unlabeled Loading Dose on Tumor-Specific Uptake of a Fluorescently Labeled Antibody for Optical Surgical Navigation 2017
2017 Laser-assisted indocyanine green dye angiography for postoperative fistulas after salvage laryngectomy 2017
2017 Beyond the margins: Real-time detection of cancer using targeted fluorophores 2017
2017 Regulatory aspects of optical methods and exogenous targets for cancer detection 2017
2017 Characterizing the utility and limitations of repurposing an open-field optical imaging device for fluorescence-guided surgery in head and neck cancer patients 2017
2017 Oncologic Procedures Amenable to Fluorescence-guided Surgery 2017
2016 Antiangiogenic antibody improves melanoma detection by fluorescently labeled therapeutic antibodies 2016
2016 Photoimmunotherapy of residual disease after incomplete surgical resection in head and neck cancer models 2016
2016 Biodistribution Study of Intravenously Injected Cetuximab-IRDye700DX in Cynomolgus Macaques 2016
2016 Fluorescence imaging to localize head and neck squamous cell carcinoma for enhanced pathological assessment 2016
2016 On the horizon: Optical imaging for cutaneous squamous cell carcinoma 2016
2016 SPARC-independent delivery of nab-paclitaxel without depleting tumor stroma in patient-derived pancreatic Cancer xenografts 2016
2016 Standardized model for predicting flap failure using indocyanine green dye 2016
2016 Successful translation of fluorescence navigation during oncologic surgery: A consensus report 2016
2015 Molecular Ultrasound Imaging of Tissue Inflammation Using an Animal Model of Acute Kidney Injury 2015
2015 Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW 2015
2015 Safety and tumor specificity of cetuximab-IRDye800 for surgical navigation in head and neck cancer 2015
2015 In Vivo Fluorescence Immunohistochemistry: Localization of Fluorescently Labeled Cetuximab in Squamous Cell Carcinomas 2015
2015 Molecular Ultrasound Imaging of Tissue Inflammation Using an Animal Model of Acute Kidney Injury 2015
2015 A ratiometric threshold for determining presence of cancer during fluorescence-guided surgery 2015
2015 Breast Cancer Imaging Using the Near-Infrared Fluorescent Agent, CLR1502. 2015
2015 Laparoscopic fluorescent visualization of the ureter with intravenous IRDye800CW 2015
2015 The status of contemporary image-guided modalities in oncologic surgery 2015
2015 Time-dependent pretreatment with bevacuzimab increases tumor specific uptake of cetuximab in preclinical oral cavity cancer studies 2015
2014 Volumetric contrast-enhanced ultrasound imaging of renal perfusion 2014
2014 A dual-reporter, diagnostic vector for prostate cancer detection and tumor imaging 2014
2014 A standardized light-emitting diode device for photoimmunotherapy 2014
2014 Antibody-based imaging strategies for cancer 2014
2014 Biodistribution of P-selectin targeted microbubbles 2014
2014 Breast cancer imaging using the near-infrared fluorescent agent, CLR1502 2014
2014 IND-Directed Safety and Biodistribution Study of Intravenously Injected Cetuximab-IRDye800 in Cynomolgus Macaques 2014
2014 Ultrasound-stimulated drug delivery for treatment of residual disease after incomplete resection of head and neck cancer 2014
2013 Alpha-CaMKII plays a critical role in determining the aggressive behavior of human osteosarcoma 2013
2013 Optical fluorescent imaging to monitor temporal effects of microbubble-mediated ultrasound therapy 2013
2013 An Animal Model Allowing Controlled Receptor Expression for Molecular Ultrasound Imaging 2013
2013 Enhancement of Adenovirus Delivery after Ultrasound-Stimulated Therapy in a Cancer Model 2013
2012 Systemic delivery of a breast cancer-detecting adenovirus using targeted microbubbles 2012
2012 Molecular targeting of ultrasonographic contrast agent for detection of head and neck squamous cell carcinoma 2012
2012 Microbubble-mediated ultrasonic techniques for improved chemotherapeutic delivery in cancer 2012
2011 Fibroblast growth factor receptor mediates fibroblast-dependent growth in EMMPRIN-depleted head and neck cancer tumor cells 2011
2011 Model System Using Controlled Receptor Expression for Evaluating Targeted Ultrasound Contrast Agents 2011
2011 A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature 2011
2011 A genetic strategy for combined screening and localized imaging of breast cancer 2011
2010 Determination of breast cancer response to bevacizumab therapy using contrast-enhanced ultrasound and artificial neural networks 2010
2009 Death receptor 5 agonist TRA8 in combination with the bisphosphonate zoledronic acid attenuated the growth of breast cancer metastasis 2009
2008 Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenograftsby diffusion-weighted magnetic resonance imaging 2008
2008 Breast tumor xenografts: Diffusion-weighted MR imaging to assess early therapy with novel apoptosis-inducing anti-DR5 antibody 2008
2008 Endotoxin-induced proteolytic reduction in hepatic growth hormone (GH) receptor: A novel mechanism for GH insensitivity 2008
Specimen mapping in head and neck cancer using fluorescence imaging.

Chapter

Year Title Altmetric
2015 Translation of therapeutic antibodies for intraoperative fluorescence imaging.  25-33. 2015

Principal Investigator On

Investigator On

  • UAB-UCSD O'Brien Center for Acute Kidney Injury Research  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2018 - 2023
  • UAB-UCSD O'Brien Center for Acute Kidney Injury Research - Core B  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2018 - 2023
  • Comprehensive Cancer Center Core Support Grant  awarded by National Cancer Institute/NIH/DHHS 2019 - 2021
  • Phase 1, Open-Label Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Cetuximab-IRDye800 as an Optical Imaging Agent to Detect Cancer during Surgical Procedures  awarded by Stanford University 2015 - 2020
  • Phase I, Open-label Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Head and Neck Cancer During Surgical Procedures  awarded by Stanford University 2015 - 2020
  • Comprehensive Cancer Center Core Support Grant  awarded by National Cancer Institute/NIH/DHHS 2017 - 2019
  • Comprehensive Cancer Center Core Support Grant - Preclinical Imaging Shared Facility  awarded by National Cancer Institute/NIH/DHHS 2017 - 2019
  • Lumina III System for UAB Optical Imaging  awarded by NIH - OFFICE OF THE DIRECTOR 2016 - 2017
  • Research Training Program in Surgical Oncology  awarded by National Cancer Institute/NIH/DHHS 2012 - 2016
  • Private Grant  awarded by LICOR, INC. 2014 - 2015
  • A Specific Screening Strategy to Reduce Prostate Cancer Mortality  awarded by DOD - ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY 2012 - 2015
  • Imaging Guided Surgery using Fluorescently Labeled Cetuximab  awarded by National Cancer Institute/NIH/DHHS 2014 - 2015
  • Full Name

  • Jason Warram